Bezlotoxumab Biosimilar - Research Grade

In stock
Only %1 left
SKU
ICH5304
Add to Compare
$732.00
Add to Wish List
More Information
Concentration 5mg/ml
isotype Human IgG1(K214R)-kappa
Host CHO Cells
Target Toxin B
Species Reactivity Human
Specificity Detects human Toxin B
Purification Method This monoclonal antibody was purified using Protein A
Formulation Sterile, preservative-free, solution in PBS. BSA and Azide free.
Purity >95% by SDS-PAGE
Endotoxin ≤ 1.0 EU/mg as determined by the LAL method
Storage This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Applications Functional Assays
Application Notes This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Use Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Write Your Own Review
You're reviewing:Bezlotoxumab Biosimilar - Research Grade
Your Rating
Who Viewed This Also Viewed
Human IgG1 Isotype Control Fab
Human IgG1 Isotype Control Fab
$306.00 - $5,100.00
Envafolimab Biosimilar - Research Grade
Envafolimab Biosimilar - Research Grade
$306.00 - $19,500.00
Bulk anti-Human CD19 (4G7) Antibody
Bulk anti-Human CD19 (4G7) Antibody
$390.00 - $2,885.00
Nemolizumab Biosimilar - Research Grade
Nemolizumab Biosimilar - Research Grade
$306.00 - $19,500.00
Adalimumab Biosimilar - Biotin Research Grade
Adalimumab Biosimilar - Biotin Research Grade
$357.00
Bulk Anti-Human iNKT Cell (6B11) Antibody
Bulk Anti-Human iNKT Cell (6B11) Antibody
$390.00 - $2,885.00
Etanercept Biosimilar - Research Grade
Etanercept Biosimilar - Research Grade
$306.00 - $19,500.00
Bulk Anti-Human CD45 (T29/33) Antibody
Bulk Anti-Human CD45 (T29/33) Antibody
$390.00 - $2,885.00
Human IgG4 Isotype Control SPLE/D265A/R409K
Human IgG4 Isotype Control SPLE/D265A/R409K
$306.00 - $5,100.00
Sotigalimab Biosimilar - Research Grade
Sotigalimab Biosimilar - Research Grade
$306.00 - $19,500.00
Back to Top